Financials
Financial year 2025
APOTHEEK VAN DEUN from Beveren-Kruibeke-Zwijndrecht, company number BE0435009960, closed financial year 2025 with a result of € 53,010 after tax. For that financial year APOTHEEK VAN DEUN recorded a gross margin of € 438,728 and equity of € 112,181. Compared with financial year 2024, the result moved from € 98,799 to € 53,010. The company is profitable. The buffer shrank hard: equity is 93 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.
€ 112,181
▼ 93% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 53,010
▼ 46% vs 2024
Profit after tax over the fiscal year.
€ 217,770
▼ 31% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 1.5 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
4.2
▲ 0.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 295,297
▲ 33% vs 2024
€ 70,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 12,691
▼ 20% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 662,024
▼ 7% vs 2024
€ 52,852 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.
€ 653,116
Supplier invoices still open on the last day of the fiscal year.
€ 29,492
▼ 4% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 134,022 | € 548,886 | € 399,685 | € 438,728 | ▲ 10% |
| Profit after taxes | € -133,474 | € 212,670 | € 98,799 | € 53,010 | ▼ 46% |
| Equity | € 1,270,712 | € 1,483,382 | € 1,562,181 | € 112,181 | ▼ 93% |
| Total debts | € 1,453,082 | € 1,370,297 | € 1,472,548 | € 1,548,921 | ▲ 5% |
| Cash | € 446,193 | € 274,185 | € 313,826 | € 217,770 | ▼ 31% |
| Land & buildings | € 306,273 | € 295,936 | € 287,628 | € 279,375 | ▼ 3% |
| Retained profit | € -265,494 | € -52,823 | € 25,975 | € 19,187 | ▼ 26% |
| Dividend | € 0 | € 0 | € 20,000 | € 1,503,010 | ▲ € 1.5 million |
| Bank debt | € 815,148 | € 764,996 | € 713,961 | € 662,024 | ▼ 7% |
| Balance sheet total | € 2,723,793 | € 2,853,679 | € 3,034,729 | € 1,661,102 | ▼ 45% |
| Employees (FTE) | 2.9 | 3.2 | 3.5 | 4.2 | ▲ 0.7 |
Key figures of APOTHEEK VAN DEUN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK VAN DEUN?
What happened at APOTHEEK VAN DEUN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 53,010 (▼ 46% vs 2024). Source: NBB ↗
- New establishment in Beveren-Kruibeke-Zwijndrecht. KBO
- Antwerp Pharmacies BV became a director. NBB
- New establishment in Beveren-Kruibeke-Zwijndrecht. KBO
- Start of the company according to the CBE. KBO
In short
From € 133,474 loss in 2022 to € 53,010 profit in 2025.
Paid € 4,018 in corporate taxes since 2022.
Best year ever: 2023, with € 212,670 profit.
On average € 104,500 of value added per employee in 2025.
A new publication or filing at APOTHEEK VAN DEUN? We notify you, reason included.
Follow APOTHEEK VAN DEUNDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ANTWERP PHARMACIES comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK VAN DEUNBehind APOTHEEK VAN DEUN is Antwerp Pharmacies BV. The shares are held by ANTWERP PHARMACIES (100%).
Directors
According to the 2025 annual accounts
Director · represented by Mees Joris
Also active at: INTERNATIONALE APOTHEEK, APOTHEEK VERLINDEN, APOTHEEK R. KROLS b.v.b.a., APOTHEEK SUYKERBUYK, APOTHEEK DIRK VAN HERCK, Farmajes, APOTHEEK PALEIS, EUROPA APOTHEEK
since 2021
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Bazelstraat 19
9150 Beveren-Kruibeke-Zwijndrecht
Bazelstraat 21
9150 Beveren-Kruibeke-Zwijndrecht
Active since 1 January 2023
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0435.009.960
- VAT number
- BE 0435.009.960
- Registered office
- Bazelstraat 19, 9150 Beveren-Kruibeke-Zwijndrecht
- Names & denominations
- APOTHEEK VAN DEUN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 August 1988
- Peppol
- Active · Active since 23 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers